Newsroom

CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), das führende Unternehmen für RNAi-Therapeutika, hat heute auf dem European Society of Cardiology (ESC) Congress 2026 neue Daten vorgestellt, die die Wirksamkeit des RNAi-basierten Gen-Silencing bei Herz-Kreislauf-Erkrankungen belegen. Die Ergebnisse untermauern das klinische Profil von AMVUTTRA® (Vutrisiran) bei Patientengruppen mit Transthyretin-Amyloidose (ATTR), in verschiedenen Behandlungskontexten und...

CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq : ALNY), société leader dans le domaine des thérapies par ARNi, a annoncé aujourd’hui, lors du congrès 2026 de la Société européenne de cardiologie (ESC), de nouvelles données démontrant l’efficacité du silençage par ARNi dans le traitement des maladies cardiovasculaires. Ces résultats renforcent encore le profil clinique d’AMVUTTRA ® (vutrisiran) chez les populations de patients atteints d’amylose à transthyrétine...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), het toonaangevende bedrijf op het gebied van RNAi-therapieën heeft vandaag tijdens het congres van de European Society of Cardiology (ESC) 2026 nieuwe gegevens bekendgemaakt die de kracht van op RNAi gebaseerde genuitschakeling bij hart- en vaatziekten aantonen. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in...

CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--  Alnylam presenta nuevos datos en el Congreso 2026 de la ESC que refuerzan la eficacia en el silenciamiento de la transtiretina mediante interferencia de ARN en poblaciones de pacientes y entornos de tratamiento de miocardiopatía amiloide por transtiretina Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), la empresa líder en terapias de interferencia de ARN, anunció nuevos datos en el Congreso 2026 de la Sociedad Europea de Cardiología (ESC) que demuestra...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), l'azienda leader nelle terapie RNAi, oggi ha annunciato nuovi dati al Congresso della European Society of Cardiology (ESC) 2026 che dimostrano l'efficacia del silenziamento basato sulla tecnologia RNAi nelle malattie cardiovascolari. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Spark OPE Ventures, operating as Spark Dealer Group (“Spark”), an operator of outdoor power equipment dealerships backed by permanent capital, today announced it has entered into a definitive agreement to acquire Louisville Outdoor Turf Products (“LOTP”), one of the largest outdoor power equipment dealers serving Louisville and the surrounding region. The transaction is expected to close during the third quarter of 2026, subject to customary closing conditions....

OAKLAND, Calif.--(BUSINESS WIRE)--e.l.f. Beauty (NYSE: ELF) and Parity today released a first-of-its-kind research report revealing a powerful, data-backed link between girls' sports participation and women’s workplace performance. The study draws on more than 9,500 respondents across the United States, Canada, Germany and the United Kingdom, making it one of the largest and broadest studies of its kind. The findings are clear and consistent: women who played sports in their youth are more like...

CHAMBERSBURG, Pa.--(BUSINESS WIRE)--GDC IT Solutions promotes Adam Reese to Director of E-Rate Sales, strengthening E-Rate strategy and support for K-12 schools....

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today the development of its Task-Aware Unified Source Separation (TUSS) technology, which enables a single AI model to separate and extract desired sounds from complex acoustic mixtures. Integrating the technology into physical AI systems in acoustically complex environments, such as manufacturing sites and public spaces, helps improve the reliability of these systems by enabling them to understand complex situatio...

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will exhibit advanced technologies and solutions as the Mitsubishi Electric Group under the theme of “Creating the Future of Industry with Physical AI – Creating new value from field knowledge through data and co-creation–” during CEATEC 2026 at Makuhari Messe in Chiba, Japan, from October 13 to 16. CEATEC is a comprehensive digital innovation exhibition where people, technology, and information from a...